Tarsus Pharmaceuticals (TARS) witnessed a jump in share price last session on above-average trading volume. The latest trend ...

Tarsus Pharmaceuticals (TARS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stars from across the globe are hitting the red carpet for this year’s European Music Awards (EMAs) in Manchester, as Rita ...

Some events, such as Culture Fest, were moved from the Spring to the Fall. It paid off, and we had a record turnout of nearly ...

Stars will descend on Manchester on Sunday for this year's MTV Europe Music Awards, with a cast list including Shawn Mendes, ...

Barclays analyst Balaji Prasad maintained a Buy rating on Tarsus Pharmaceuticals (TARS – Research Report) today and set a price target of ...

Harbor Capital Advisors Inc. raised its holdings in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 57.5% in the third quarter, according to the company in its most recent filing ...

On Tuesday, Tarsus Pharmaceuticals Inc (TARS) stock saw a modest uptick, ending the day at $43.87 which represents a slight increase of $4.20 or 10.59% from the prior close of $39.67. The stock opened ...

Tarsus Pharmaceuticals, Inc. (TARS) shares ended the last trading session 10.6% higher at $43.87. The jump came on an impressive volume with a higher-than-average number of shares changing hands ...

View Tarsus Pharmaceuticals, Inc. (TARS) current and estimated P/E ratio data provided by Seeking Alpha.